Document Classification

Section Type: RESULTS

Text: Mean (standard error) changes from baseline in the fostamatinib 100 mg bid group versus the placebo group were -31. 3 (2. 45) versus -17. 8 (2. 45), p < 0. 001 for pain ; -29. 1 (2. 26) versus -16. 7 (2. 42), p < 0. 001 for PtGA ; -0. 647 (0. 064) versus -0. 343 (0. 062), p < 0. 001 for physical function ; 7. 40 (1. 00) versus 4. 50 (0. 94), p < 0. 05 for fatigue ; 8. 52 (0. 77) versus 4. 90 (0. 78), p < 0. 01 for SF-36 physical component score ; and 3. 99 (0. 93) versus 3. 71 (0. 99), p = 0. 83 for SF-36 mental component score.